10times
06 May 2021Ended

The Approach To Rare Hematological Disease

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

upto 1000
Visitors

20 - 100 Exhibitors Based on previous editions

Editions

May 2021

Frequency

Not Available
Claim event to edit details

In this meeting we are going to refer to all of them as a whole and, particularly to Hemophilia, a hereditary bleeding disorder in which the blood .. Read more does not clot properly, and Acquired Thrombotic Thrombocytopenic Purpura (aTTP), a rare thrombotic microangiopathy , which can be life-threatening and is characterized by hemolytic anemia, severe thrombocytopenia, and tissue ischemia. Today we are going to discuss the nature of drugs for these diseases and high impact drug management models. We are going to show how the lives of these patients have changed. The objectives of this meeting are: to show the unmet needs in these pathologies, to know the state of the art of research on rare hematological diseases and to defend the incentives for MMHH. In this sense, we intend that both the agencies and regulatory entities and funders of these treatments, as well as health professionals, patients and the media participate in the knowledge generated and revealed in this meeting, become aware of the opportunities that arise. offer and make the decision to work for the solution of the problems raised.

  • Share your Experience
  • Organizer
Logo Follow Company

Fundacion Bamberg

13 Total Events / 1 Upcoming Event

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results